Characteristics | No. | OS | Â | RFS | Â |
---|---|---|---|---|---|
 |  | HR (95% CI) | P | HR (95% CI) | P |
Age, years, ≥ 30 (vs. <30) | 13/37 | 2.398 (0.938–6.134) | 0.068 | 2.925 (1.210–7.070) | 0.017 |
Sex, male (vs. female) | 25/37 | 1.140 (0.402–3.229) | 0.806 | 1.513 (0.541–4.228) | 0.430 |
Tumor size, > 8 cm (vs. ≤ 8 cm) | 18/37 | 3.975 (1.401–11.280) | 0.010 | 3.067 (1.204–7.813) | 0.019 |
Stage, ≥ II (vs.. I) | 26/37 | 4.829 (1.107–21.058) | 0.036 | 3.267 (0.953–11.206) | 0.060 |
Histologic grade, 3 & 4 (vs. 1 & 2) | 27/37 | 4.502 (1.031–19.666) | 0.045 | 5.130 (1.184–22.222) | 0.029 |
Lymph node metastasis, presence (vs.. absence) | 3/37 | 5.373 (1.026–28.150) | 0.047 | 2.981 (0.628–14.142) | 0.169 |
Distant metastasis, presence (vs. absence) | 7/37 | 5.347 (1.793–15.950) | 0.003 | 3.802 (1.295–11.163) | 0.015 |
SIRT6, positive (vs. negative) | 18/37 | 4.012 (1.419–11.344) | 0.009 | 4.151 (1.570-10.971) | 0.004 |